Who we are

Vaxx Research Incorporated (VAXX) is a Canadian biotech company pioneering AI and blockchain-powered drug discovery to develop breakthrough treatments.  Our CureiTec™ AI/ML platform drives the creation of AI-assisted RNA vaccines (ARVAC™) and Adoptive Cell Therapies (ARCS™) to tackle complex diseases.  By integrating AI with advanced biotechnology, we accelerate drug development and improve access to life-changing therapies.